Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02861820 · ClinicalTrials.gov registry record
Functional Connectivity Changes During Early Recovery as a Marker for Relapse
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 160
- Enrollment target
NCT02861820 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 160 participants.
The verdict
NCT02861820 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
Study Summary
The study purpose is to examine whether there are structural or functional differences in the brains of individuals who use cocaine or amphetamines as opposed to control participants who have never used cocaine or amphetamines. More specifically, it will allow the investigator to see how the brain changes once people get sober and how those changes relate to successful recovery. This study will allow the investigator to examine the interaction between cocaine/amphetamines and impulsivity (meaning to act on impulse rather than thought). Results from this study will inform new biologically-based interventions to compliment existing treatment programs, in the hope of leading the field in a new direction.
Interventions
- DEVICE MRI: Brain Imaging Data Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2015-07-01 |
| Est. Completion | 2021-01-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02861820
The ClinicalTrials.gov registry entry for NCT02861820 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI: Brain Imaging Data Collection is the first listed.
NCT02861820 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02861820 about?
NCT02861820 is a clinical study titled "Functional Connectivity Changes During Early Recovery as a Marker for Relapse". The study purpose is to examine whether there are structural or functional differences in the brains of individuals who use cocaine or amphetamines as opposed to control participants who have never used cocaine or amphetamines. More specifically, it will allow the investigator to see how the brain c...
What is the current status of trial NCT02861820?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2015-07-01. Estimated completion is 2021-01-26.
What interventions are being tested in trial NCT02861820?
The interventions under investigation include: MRI: Brain Imaging Data Collection (DEVICE).
Who is sponsoring clinical trial NCT02861820?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.